Frankie Fattorini

The study published in Nature shows the drastic economic cost of obesity through medical expenses and lost productivity. Credit: zimmytws/Getty Images A new study published in Nature estimates the economic burden associated with obesity on major US industries to have […]

Life sciences analysts discussed the sector’s future following US, EU, and UK elections at the Jefferies London Healthcare Conference 2024. Credit: Frankie Fattorini/GlobalData The outcomes of this year’s US, EU, and UK elections and their downstream effects will lead to

Experts disagree on whether DPIs or low emissions pMDIs are the way forward for effective, environmentally friendly inhalers. Credit: Pixel-Shot/Shutterstock In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder

Minister for Science Lord Vallance said Labour seek closer ties with commercial clinical industry to ignite innovation. Credit: Frankie Fattorini/GlobalData Lord Patrick Vallance has emphasised plans for a close collaboration between the government and private sector, in line with the

The Danish companies aim to jointly develop a GLP-1RA administered once a month. Credit: Kittyfly / Shutterstock Novo Nordisk and Ascendis Pharma have agreed to collaborate in developing metabolic and cardiovascular therapies, among them a once-monthly glucagon-like peptide receptor agonist

Pfizer CEO Dr Albert Bourla presided over an exceptional Q3 amid financial decline and pressure from investor Starboard Value. Credit: Ververidis Vasilis / Shutterstock. Pfizer has reported strong revenues in its latest earnings report, noting increased revenues over Q3 2023

: SP-624 may treat depression in women by modulating the distinct female genetic profile. Credit: Prathankarnpap/Shutterstock Arrivo BioVentures’ SIRT6 activator SP-624 has been found to significantly reduce symptoms of major depressive disorder (MDD), but only in women. Steve Butts, Arrivo

J&J’s Darzalex-VRd can now be given to newly diagnosed MM patients eligible for ASCT. Credit: Michael Vi/Shutterstock The European label for Johnson and Johnson Innovation Medicine’s (J&J) Darzalex (daratumumab) has been expanded to include patients with newly diagnosed multiple myeloma

Self-amplifying vaccines promise extended efficacy with lower doses than their mRNA predecessors, but approvals have been slow to materialize. Credit: Javier Zayas Photography/ Getty Images A year after bursting onto the scene amid the RNA renaissance, scientific challenges and regulatory

Genevant LNP technology will provide a vehicle for Editas’ CRISPR/Cas12a gene therapy. Credit: ART-ur / Shutterstock. Editas Medicine and Genevant Sciences will collaborate to develop gene editing therapies, employing their respective CRISPR and LNP technologies under a nonexclusive licencing agreement.